Guangdong Second Provincial General Hospital: Clinical Trials

36 trials sponsored by Guangdong Second Provincial General Hospital, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 recruiting, 10 unknown, 6 not yet recruiting, 4 completed. 11 Not applicable, 7 Phase 2, 4 Phase 3, 3 Phase 4, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable11Completed 3, Not yet recruiting 3, Recruiting 3, Unknown 2
Phase 27Enrolling by invitation 3, Recruiting 2, Not yet recruiting 1, Withdrawn 1
Phase 34Completed 1, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1
Phase 43Not yet recruiting 1, Recruiting 1, Unknown 1
Early Phase 12Not yet recruiting 1, Unknown 1
Phase 11Recruiting 1

Follow Guangdong Second Provincial General Hospital: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II Study of Anlotinib + PD-1 Inhibitor vs. PD-1 Inhibitor Maintenance After First-Line Chemoimmunotherapy in Advanced ESCC (Esophageal Squamous Cell Carcinoma)
anlotinib + PD-1 inhibitor, PD-1 inhibitor - Esophageal Cancer (EC)
Phase 2RecruitingSun Yat-sen University1122026-10-122026-10-07
Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure
Lisaftoclax (APG-2575), homoharringtonine, Azacitidine (AZA) - Acute Myeloid Leukemia (AML)
Phase 2Enrolling by invitationGuangdong Second Provincial General Hospital732026-09-012026-09-10
Chidamide in HR-AML
Acute Myeloid Leukemia, Maintenance Therapy
Active not recruitingGuangdong Second Provincial General Hospital332026-07-272026-09-16
Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment
Intrasaccular Flow Disruption Device - Intracranial Aneurysm
RecruitingXuanwu Hospital, Beijing10002026-06-102026-06-11
Luspatercept for CIA in AML
Luspatercept Injectable Product - Chemotherapy-inducing Anemia
Phase 1 / Phase 2RecruitingGuangdong Second Provincial General Hospital402026-06-012026-06-23
Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China
endovascular - Intracranial Dural Arteriovenous Fistula
RecruitingXuanwu Hospital, Beijing100502026-05-182026-06-04
VEN+IDAC vs IDAC in AML
Ventoclax, Cytarabine - AML (Acute Myelogenous Leukemia)
Phase 2 / Phase 3Enrolling by invitationGuangdong Second Provincial General Hospital2322026-04-012026-04-17
FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer
Standard First-Line Therapy, FMT Combined with Standard First-Line Therapy - Unresectable Colorectal Cancer, Colorectal Cancer (Locally Advanced or Metastatic)
Phase 2 / Phase 3Not yet recruitingShanghai 10th People's Hospital2202026-04-012026-04-03
HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL).
HVA - Newly Diagnosed Mixed Phenotype Acute Leukemia (MPAL)
Phase 2Enrolling by invitationGuangdong Second Provincial General Hospital402026-04-012026-04-08
Exploring the Clinical Value of an AI-Assisted Patient Self-Assessment App for Bowel Preparation: A Multicenter Study
The app group - Bowel Preparation for Colonoscopy, Colonoscopy
Not applicableNot yet recruitingSixth Affiliated Hospital, Sun Yat-sen University5242026-01-012026-01-21
Efficacy and Safety of the RDI Mode in Endoscopic Submucosal Dissection
RDI - Endoscopic Submucosal Dissection (ESD)
Not applicableNot yet recruitingSixth Affiliated Hospital, Sun Yat-sen University1582026-01-012026-01-26
SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
SIS-reinforced anastomosis - Rectal Cancer
Phase 4RecruitingBeijing Chao Yang Hospital9662025-10-212026-06-17
Rescue Endovascular Treatment After Neurological Deterioration in Initially Mild Basilar Artery Occlusion in an Extended Time Window
Endovascular Treatment - Acute Mild Ischemic Stroke, Basilar Artery Occlusion
Not applicableRecruitingFirst Affiliated Hospital of Wannan Medical College1592025-08-012026-09-16
EVT in Acute Basilar Artery Occlusion With Large Infarction Core
Endovascular Treatment - Basilar Artery Occlusion, Large Ischemic Core
Not applicableRecruitingThe First Affiliated Hospital of Hainan Medical University3722025-08-012026-09-04
18F-FDG PET/CT Radiomics Models for Precision Diagnosis and Prognosis in NSCLC
Non Small Cell Lung Cancer
Active not recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine5002025-07-012026-03-04
Mobile Phone Thermal Imaging Assessment of Incompetent Perforator Veins
Mobile phone thermal imaging - Chronic Venous Disease
Not applicableNot yet recruitingGuangdong Second Provincial General Hospital1002025-03-012025-02-19
CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML
Cladribine, Cytarabine, G-CSF - Relapsed/Refractory AML
Phase 4Not yet recruitingNanfang Hospital, Southern Medical University1722025-02-012025-01-08
To Assess the Effectiveness and Safety of Catheter-based Focal Intracranial Hypothermia Combined With Endovascular Reperfusion Therapy for Patients With Acute Anterior Circulation Large Artery Occlusion
Mechanical thrombectomy, 4°C saline infusion, Normothermic saline infusion - Acute Cerebrovascular Accident, Acute Ischemic Stroke
Not applicableCompletedGuangdong Second Provincial General Hospital2622025-01-232026-10-14
HVA vs IA/DA or VA in the Treatment of ND HR-AML
HVA, VA, Standard Chemotherapy - Newly Diagnosed Acute Myeloid Leukemia With High Risk
Phase 3RecruitingNanfang Hospital, Southern Medical University8762025-01-012025-02-06
A Hierarchical Multi-modal AI Framework for Pathological and Genetic Subtyping of Lung Cancer Based on PET/CT Imaging
PET imaging analysis, data mining, and AI model developing - Lung Cancer
RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine55002024-08-012026-03-11

Showing 20 of 36. Sign in to see all of them.

Conditions studied

Leukemia, Myeloid, Acute (6)  ·  Acute Pain (2)  ·  Neoplasm, Residual (2)  ·  Pain, Postoperative (2)  ·  Rectal Neoplasms (2)  ·  Recurrence (2)  ·  Risk Reduction Behavior (2)  ·  Stroke (2)  ·  Anemia (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Cerebral Hemorrhage (1)  ·  Cerebral Infarction (1)  ·  Cerebrovascular Disorders (1)  ·  Colorectal Neoplasms (1)  ·  Diabetes Mellitus, Type 2 (1)

Interventions

Cytarabine (2)  ·  Endoscopy, Digestive System (2)  ·  Azacitidine (1)  ·  Blood Transfusion (1)  ·  Busulfan (1)  ·  Cladribine (1)  ·  Cyclophosphamide (1)  ·  Endoscopy (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Homoharringtonine (1)  ·  Immune Checkpoint Inhibitors (1)  ·  Lisaftoclax (1)  ·  Noninvasive Ventilation (1)  ·  Octreotide (1)

Countries

China (32)  ·  Thailand (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Guopan Yu (2)  ·  Qing Zhang, Doctoral (2)  ·  Xiaolong Qi, MD (2)  ·  Guopan Yu, PhD (1)  ·  Hong Zhang (1)  ·  Hongqi Zhang (1)  ·  Hongwei Zhou, PhD (1)  ·  Qian Liu (1)  ·  Qifa Liu (1)  ·  Rongchang Chen, MD (1)  ·  Shenghong Ju, MD (1)  ·  Simin Wang (1)  ·  Xiaohui Zhang (1)  ·  Xiaolong Qi, M.D. (1)  ·  Xin Su (1)

Results publications

PMID 31807567, PMID 33074566, PMID 34327406, PMID 36084276, PMID 36638337, PMID 38095714, PMID 39922696, PMID 41816520, PMID 42790919